{"entity":{"type":"insider","cik":"0001492710","url":"/insider/0001492710","json_url":"/insider/0001492710.json","name":"Freitag Gregory Gene","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":26,"n_filings":18,"first":"2011-11-23","last":"2025-03-03","span_basis":"filed_date"},"name_variants":[{"name":"Freitag Gregory Gene","source":"filing","n_filings":18,"first_seen":"2011-11-23","last_seen":"2025-03-03"}],"transactions":[{"id":4844167,"accession":"0001140361-25-006784","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-25-006784","line_url":"/filing/0001140361-25-006784#line-1","is_derivative":false,"issuer_cik":"0001472091","issuer_name":"PDS Biotechnology Corp","issuer_ticker":"PDSB","issuer_name_source":null,"issuer_url":"/issuer/0001472091","owner_cik":"0001492710","owner_name":"Freitag Gregory Gene","owner_display_name":"Freitag Gregory Gene","owner_url":"/insider/0001492710","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15060.0,"shares_display":"15,060","price_per_share":1.66,"price_display":"1.66","price_state":"stated","total_value":24999.6,"total_display":"24,999.60","total_whole":"25,000","shares_owned_after":61213.0,"shares_owned_after_display":"61,213","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-28","filed_date":"2025-03-03","scope":"insider"},{"id":2620261,"accession":"0000805928-24-000039","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000805928-24-000039","line_url":"/filing/0000805928-24-000039#line-1","is_derivative":false,"issuer_cik":"0000805928","issuer_name":"Axogen, Inc.","issuer_ticker":"AXGN","issuer_name_source":null,"issuer_url":"/issuer/0000805928","owner_cik":"0001492710","owner_name":"Freitag Gregory Gene","owner_display_name":"Freitag Gregory Gene","owner_url":"/insider/0001492710","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":9.0,"price_display":"9.00","price_state":"stated","total_value":225000.0,"total_display":"225,000.00","total_whole":"225,000","shares_owned_after":271594.0,"shares_owned_after_display":"271,594","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-07","filed_date":"2024-03-08","scope":"insider"},{"id":8099938,"accession":"0000805928-23-000062","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000805928-23-000062","line_url":"/filing/0000805928-23-000062","is_derivative":false,"issuer_cik":"0000805928","issuer_name":"Axogen, Inc.","issuer_ticker":"AXGN","issuer_name_source":null,"issuer_url":"/issuer/0000805928","owner_cik":"0001492710","owner_name":"Freitag Gregory Gene","owner_display_name":"Freitag Gregory Gene","owner_url":"/insider/0001492710","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":41980.0,"shares_display":"41,980","price_per_share":8.713201524535494,"price_display":"8.71","price_state":"stated","total_value":365780.2,"total_display":"365,780.20","total_whole":"365,780","shares_owned_after":290135.0,"shares_owned_after_display":"290,135","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-01","filed_date":"2023-06-05","scope":"insider","n_lines":2},{"id":8308997,"accession":"0000805928-23-000056","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000805928-23-000056","line_url":"/filing/0000805928-23-000056","is_derivative":false,"issuer_cik":"0000805928","issuer_name":"Axogen, Inc.","issuer_ticker":"AXGN","issuer_name_source":null,"issuer_url":"/issuer/0000805928","owner_cik":"0001492710","owner_name":"Freitag Gregory Gene","owner_display_name":"Freitag Gregory Gene","owner_url":"/insider/0001492710","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7468.0,"shares_display":"7,468","price_per_share":9.225918585966792,"price_display":"9.23","price_state":"stated","total_value":68899.16,"total_display":"68,899.16","total_whole":"68,899","shares_owned_after":332115.0,"shares_owned_after_display":"332,115","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-23","filed_date":"2023-05-24","scope":"insider","n_lines":2},{"id":6531338,"accession":"0000805928-22-000121","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000805928-22-000121","line_url":"/filing/0000805928-22-000121#line-1","is_derivative":false,"issuer_cik":"0000805928","issuer_name":"Axogen, Inc.","issuer_ticker":"AXGN","issuer_name_source":null,"issuer_url":"/issuer/0000805928","owner_cik":"0001492710","owner_name":"Freitag Gregory Gene","owner_display_name":"Freitag Gregory Gene","owner_url":"/insider/0001492710","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13000.0,"shares_display":"13,000","price_per_share":12.74,"price_display":"12.74","price_state":"stated","total_value":165620.0,"total_display":"165,620.00","total_whole":"165,620","shares_owned_after":339583.0,"shares_owned_after_display":"339,583","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-14","filed_date":"2022-11-16","scope":"insider"},{"id":6289705,"accession":"0000805928-22-000119","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000805928-22-000119","line_url":"/filing/0000805928-22-000119#line-1","is_derivative":false,"issuer_cik":"0000805928","issuer_name":"Axogen, Inc.","issuer_ticker":"AXGN","issuer_name_source":null,"issuer_url":"/issuer/0000805928","owner_cik":"0001492710","owner_name":"Freitag Gregory Gene","owner_display_name":"Freitag Gregory Gene","owner_url":"/insider/0001492710","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13000.0,"shares_display":"13,000","price_per_share":12.5,"price_display":"12.50","price_state":"stated","total_value":162500.0,"total_display":"162,500.00","total_whole":"162,500","shares_owned_after":352583.0,"shares_owned_after_display":"352,583","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-08","filed_date":"2022-11-10","scope":"insider"},{"id":6972670,"accession":"0000805928-22-000107","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000805928-22-000107","line_url":"/filing/0000805928-22-000107#line-1","is_derivative":false,"issuer_cik":"0000805928","issuer_name":"Axogen, Inc.","issuer_ticker":"AXGN","issuer_name_source":null,"issuer_url":"/issuer/0000805928","owner_cik":"0001492710","owner_name":"Freitag Gregory Gene","owner_display_name":"Freitag Gregory Gene","owner_url":"/insider/0001492710","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8886.0,"shares_display":"8,886","price_per_share":9.696,"price_display":"9.70","price_state":"stated","total_value":86158.656,"total_display":"86,158.66","total_whole":"86,159","shares_owned_after":365583.0,"shares_owned_after_display":"365,583","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-10","filed_date":"2022-08-11","scope":"insider"},{"id":6712598,"accession":"0000805928-22-000105","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000805928-22-000105","line_url":"/filing/0000805928-22-000105#line-2","is_derivative":false,"issuer_cik":"0000805928","issuer_name":"Axogen, Inc.","issuer_ticker":"AXGN","issuer_name_source":null,"issuer_url":"/issuer/0000805928","owner_cik":"0001492710","owner_name":"Freitag Gregory Gene","owner_display_name":"Freitag Gregory Gene","owner_url":"/insider/0001492710","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13046.0,"shares_display":"13,046","price_per_share":10.37,"price_display":"10.37","price_state":"stated","total_value":135287.02,"total_display":"135,287.02","total_whole":"135,287","shares_owned_after":374469.0,"shares_owned_after_display":"374,469","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-08","filed_date":"2022-08-08","scope":"insider"},{"id":6712594,"accession":"0000805928-22-000105","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000805928-22-000105","line_url":"/filing/0000805928-22-000105#line-1","is_derivative":false,"issuer_cik":"0000805928","issuer_name":"Axogen, Inc.","issuer_ticker":"AXGN","issuer_name_source":null,"issuer_url":"/issuer/0000805928","owner_cik":"0001492710","owner_name":"Freitag Gregory Gene","owner_display_name":"Freitag Gregory Gene","owner_url":"/insider/0001492710","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24000.0,"shares_display":"24,000","price_per_share":10.64,"price_display":"10.64","price_state":"stated","total_value":255360.0,"total_display":"255,360.00","total_whole":"255,360","shares_owned_after":387515.0,"shares_owned_after_display":"387,515","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-04","filed_date":"2022-08-08","scope":"insider"},{"id":5451141,"accession":"0001140361-21-021489","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-21-021489","line_url":"/filing/0001140361-21-021489#line-1","is_derivative":false,"issuer_cik":"0001472091","issuer_name":"PDS Biotechnology Corp","issuer_ticker":"PDSB","issuer_name_source":null,"issuer_url":"/issuer/0001472091","owner_cik":"0001492710","owner_name":"Freitag Gregory Gene","owner_display_name":"Freitag Gregory Gene","owner_url":"/insider/0001492710","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5882.0,"shares_display":"5,882","price_per_share":8.5,"price_display":"8.50","price_state":"stated","total_value":49997.0,"total_display":"49,997.00","total_whole":"49,997","shares_owned_after":46153.0,"shares_owned_after_display":"46,153","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-15","filed_date":"2021-06-17","scope":"insider"},{"id":4202878,"accession":"0000805928-21-000046","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000805928-21-000046","line_url":"/filing/0000805928-21-000046#line-1","is_derivative":false,"issuer_cik":"0000805928","issuer_name":"Axogen, Inc.","issuer_ticker":"AXGN","issuer_name_source":null,"issuer_url":"/issuer/0000805928","owner_cik":"0001492710","owner_name":"Freitag Gregory Gene","owner_display_name":"Freitag Gregory Gene","owner_url":"/insider/0001492710","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24000.0,"shares_display":"24,000","price_per_share":22.06,"price_display":"22.06","price_state":"stated","total_value":529440.0,"total_display":"529,440.00","total_whole":"529,440","shares_owned_after":228352.0,"shares_owned_after_display":"228,352","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-25","filed_date":"2021-03-01","scope":"insider"},{"id":2708661,"accession":"0001179110-20-012293","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-20-012293","line_url":"/filing/0001179110-20-012293#line-2","is_derivative":false,"issuer_cik":"0000805928","issuer_name":"Axogen, Inc.","issuer_ticker":"AXGN","issuer_name_source":null,"issuer_url":"/issuer/0000805928","owner_cik":"0001492710","owner_name":"Freitag Gregory Gene","owner_display_name":"Freitag Gregory Gene","owner_url":"/insider/0001492710","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":916.0,"shares_display":"916","price_per_share":17.81,"price_display":"17.81","price_state":"stated","total_value":16313.96,"total_display":"16,313.96","total_whole":"16,314","shares_owned_after":248345.0,"shares_owned_after_display":"248,345","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-29","filed_date":"2020-12-30","scope":"insider"},{"id":2527861,"accession":"0001179110-20-012171","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-20-012171","line_url":"/filing/0001179110-20-012171#line-2","is_derivative":false,"issuer_cik":"0000805928","issuer_name":"Axogen, Inc.","issuer_ticker":"AXGN","issuer_name_source":null,"issuer_url":"/issuer/0000805928","owner_cik":"0001492710","owner_name":"Freitag Gregory Gene","owner_display_name":"Freitag Gregory Gene","owner_url":"/insider/0001492710","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":379.0,"shares_display":"379","price_per_share":16.42,"price_display":"16.42","price_state":"stated","total_value":6223.18,"total_display":"6,223.18","total_whole":"6,223","shares_owned_after":245076.0,"shares_owned_after_display":"245,076","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-21","filed_date":"2020-12-22","scope":"insider"},{"id":6348923,"accession":"0001179110-18-013429","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-18-013429","line_url":"/filing/0001179110-18-013429#line-1","is_derivative":false,"issuer_cik":"0000805928","issuer_name":"AxoGen, Inc.","issuer_ticker":"AXGN","issuer_name_source":null,"issuer_url":"/issuer/0000805928","owner_cik":"0001492710","owner_name":"Freitag Gregory Gene","owner_display_name":"Freitag Gregory Gene","owner_url":"/insider/0001492710","role":"Director, Officer (General Counsel)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":45000.0,"shares_display":"45,000","price_per_share":33.0,"price_display":"33.00","price_state":"stated","total_value":1485000.0,"total_display":"1,485,000.00","total_whole":"1,485,000","shares_owned_after":95865.0,"shares_owned_after_display":"95,865","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-11-30","filed_date":"2018-12-04","scope":"insider"},{"id":6546101,"accession":"0001179110-18-012899","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-18-012899","line_url":"/filing/0001179110-18-012899#line-1","is_derivative":false,"issuer_cik":"0000805928","issuer_name":"AxoGen, Inc.","issuer_ticker":"AXGN","issuer_name_source":null,"issuer_url":"/issuer/0000805928","owner_cik":"0001492710","owner_name":"Freitag Gregory Gene","owner_display_name":"Freitag Gregory Gene","owner_url":"/insider/0001492710","role":"Director, Officer (General Counsel)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":32.25,"price_display":"32.25","price_state":"stated","total_value":645000.0,"total_display":"645,000.00","total_whole":"645,000","shares_owned_after":140865.0,"shares_owned_after_display":"140,865","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-11-15","filed_date":"2018-11-15","scope":"insider"},{"id":7053947,"accession":"0001209191-14-038970","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-038970","line_url":"/filing/0001209191-14-038970#line-2","is_derivative":false,"issuer_cik":"0000805928","issuer_name":"AxoGen, Inc.","issuer_ticker":"AXGN","issuer_name_source":null,"issuer_url":"/issuer/0000805928","owner_cik":"0001492710","owner_name":"Freitag Gregory Gene","owner_display_name":"Freitag Gregory Gene","owner_url":"/insider/0001492710","role":"Director, Officer (CFO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":200.0,"shares_display":"200","price_per_share":2.34,"price_display":"2.34","price_state":"stated","total_value":468.0,"total_display":"468.00","total_whole":"468","shares_owned_after":29518.0,"shares_owned_after_display":"29,518","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-06-03","filed_date":"2014-06-04","scope":"insider"},{"id":7053944,"accession":"0001209191-14-038970","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-14-038970","line_url":"/filing/0001209191-14-038970#line-1","is_derivative":false,"issuer_cik":"0000805928","issuer_name":"AxoGen, Inc.","issuer_ticker":"AXGN","issuer_name_source":null,"issuer_url":"/issuer/0000805928","owner_cik":"0001492710","owner_name":"Freitag Gregory Gene","owner_display_name":"Freitag Gregory Gene","owner_url":"/insider/0001492710","role":"Director, Officer (CFO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":2.45,"price_display":"2.45","price_state":"stated","total_value":12250.0,"total_display":"12,250.00","total_whole":"12,250","shares_owned_after":29318.0,"shares_owned_after_display":"29,318","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-06-02","filed_date":"2014-06-04","scope":"insider"},{"id":4609712,"accession":"0001209191-13-040859","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-13-040859","line_url":"/filing/0001209191-13-040859#line-1","is_derivative":false,"issuer_cik":"0000805928","issuer_name":"AxoGen, Inc.","issuer_ticker":"AXGN","issuer_name_source":null,"issuer_url":"/issuer/0000805928","owner_cik":"0001492710","owner_name":"Freitag Gregory Gene","owner_display_name":"Freitag Gregory Gene","owner_url":"/insider/0001492710","role":"Director, Officer (CFO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":8334.0,"shares_display":"8,334","price_per_share":3.0,"price_display":"3.00","price_state":"stated","total_value":25002.0,"total_display":"25,002.00","total_whole":"25,002","shares_owned_after":32652.0,"shares_owned_after_display":"32,652","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-08-14","filed_date":"2013-08-15","scope":"insider"},{"id":2643236,"accession":"0001209191-12-000342","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-12-000342","line_url":"/filing/0001209191-12-000342#line-1","is_derivative":false,"issuer_cik":"0000805928","issuer_name":"AxoGen, Inc.","issuer_ticker":"AXGN","issuer_name_source":null,"issuer_url":"/issuer/0000805928","owner_cik":"0001492710","owner_name":"Freitag Gregory Gene","owner_display_name":"Freitag Gregory Gene","owner_url":"/insider/0001492710","role":"Director, Officer (CFO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":9318.0,"shares_display":"9,318","price_per_share":2.4,"price_display":"2.40","price_state":"stated","total_value":22363.2,"total_display":"22,363.20","total_whole":"22,363","shares_owned_after":24318.0,"shares_owned_after_display":"24,318","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-12-30","filed_date":"2012-01-03","scope":"insider"},{"id":9025977,"accession":"0001209191-11-057935","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-11-057935","line_url":"/filing/0001209191-11-057935","is_derivative":false,"issuer_cik":"0000805928","issuer_name":"AxoGen, Inc.","issuer_ticker":"AXGN","issuer_name_source":null,"issuer_url":"/issuer/0000805928","owner_cik":"0001492710","owner_name":"Freitag Gregory Gene","owner_display_name":"Freitag Gregory Gene","owner_url":"/insider/0001492710","role":"Director, Officer (CFO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":9000.0,"shares_display":"9,000","price_per_share":2.9166666666666665,"price_display":"2.92","price_state":"stated","total_value":26250.0,"total_display":"26,250.00","total_whole":"26,250","shares_owned_after":15000.0,"shares_owned_after_display":"15,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-11-22","filed_date":"2011-11-23","scope":"insider","n_lines":2},{"id":9025975,"accession":"0001209191-11-057935","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-11-057935","line_url":"/filing/0001209191-11-057935","is_derivative":false,"issuer_cik":"0000805928","issuer_name":"AxoGen, Inc.","issuer_ticker":"AXGN","issuer_name_source":null,"issuer_url":"/issuer/0000805928","owner_cik":"0001492710","owner_name":"Freitag Gregory Gene","owner_display_name":"Freitag Gregory Gene","owner_url":"/insider/0001492710","role":"Director, Officer (CFO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6000.0,"shares_display":"6,000","price_per_share":2.8991666666666664,"price_display":"2.90","price_state":"stated","total_value":17395.0,"total_display":"17,395.00","total_whole":"17,395","shares_owned_after":6000.0,"shares_owned_after_display":"6,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-11-21","filed_date":"2011-11-23","scope":"insider","n_lines":3}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":26,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":11,"open_market":true},{"code":"S","label":"Open-market sale","n":15,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":26},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001472091","name":"PDS Biotechnology Corp","url":"/issuer/0001472091","role":"Director","n_filings":2,"first_seen":"2021-06-17","last_seen":"2025-03-03"},{"type":"issuer","type_label":"ISSUER","cik":"0000805928","name":"Axogen, Inc.","url":"/issuer/0000805928","role":"Director, Officer (General Counsel)","n_filings":16,"first_seen":"2011-11-23","last_seen":"2024-03-08"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001492710","retrieved_at":"2026-08-25T02:25:42+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}